Latest profit margin for Mallinckrodt Plc - New: -46.13% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Mallinckrodt Plc - New posts a profit margin of -46.13% as of September 2026. That compares with 68.01% in the prior-year period — down 167.8% year over year. That is below the Healthcare sector average of 17.63%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Mallinckrodt Plc - New's profit margin was 68.01%. The latest reading is -46.13% — a 167.8% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.
For Healthcare stocks, a profit margin near 17.63% is typical. Mallinckrodt Plc - New's -46.13% is lower that level. That is roughly 361.7% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Mallinckrodt Plc - New's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -46.13% as of September 2026; use YoY and peer views to separate noise from signal.
Context for MNK's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 17.63%), and (3) consistency with growth and profitability. This page covers the first two; Mallinckrodt Plc - New's other metric pages and overview cover the third.